Magnesium and Human Health: Perspectives and Research Directions

Abdullah M Al Alawi, Sandawana William Majoni, Henrik Falhammar, Abdullah M Al Alawi, Sandawana William Majoni, Henrik Falhammar

Abstract

Magnesium is the fourth most abundant cation in the body. It has several functions in the human body including its role as a cofactor for more than 300 enzymatic reactions. Several studies have shown that hypomagnesemia is a common electrolyte derangement in clinical setting especially in patients admitted to intensive care unit where it has been found to be associated with increase mortality and hospital stay. Hypomagnesemia can be caused by a wide range of inherited and acquired diseases. It can also be a side effect of several medications. Many studies have reported that reduced levels of magnesium are associated with a wide range of chronic diseases. Magnesium can play important therapeutic and preventive role in several conditions such as diabetes, osteoporosis, bronchial asthma, preeclampsia, migraine, and cardiovascular diseases. This review is aimed at comprehensively collating the current available published evidence and clinical correlates of magnesium disorders.

Figures

Figure 1
Figure 1
Magnesium balance in the human body.
Figure 2
Figure 2
Impact of hypomagnesemia.

References

    1. Bertinato J., Wu Xiao C., Ratnayake W. M., et al. Lower serum magnesium concentration is associated with diabetes, insulin resistance, and obesity in South Asian and white Canadian women but not men. Food & Nutrition Research. 2015;59(1, article 25974) doi: 10.3402/fnr.v59.25974.
    1. Grober U., Schmidt J., Kisters K. Magnesium in prevention and therapy. Nutrients. 2015;7(9):8199–8226. doi: 10.3390/nu7095388.
    1. de Baaij J. H. F., Hoenderop J. G. J., Bindels R. J. M. Magnesium in man: implications for health and disease. Physiological Reviews. 2015;95(1):1–46. doi: 10.1152/physrev.00012.2014.
    1. Jahnen-Dechent W., Ketteler M. Magnesium basics. Clinical Kidney Journal. 2012;5(Supplement 1):i3–i14. doi: 10.1093/ndtplus/sfr163.
    1. Olza J., Aranceta-Bartrina J., Gonzalez-Gross M., et al. Reported dietary intake, disparity between the reported consumption and the level needed for adequacy and food sources of calcium, phosphorus, magnesium and vitamin D in the Spanish population: findings from the ANIBES study †. Nutrients. 2017;9(2) doi: 10.3390/nu9020168.
    1. William J. H., Danziger J. Proton-pump inhibitor-induced hypomagnesemia: current research and proposed mechanisms. World Journal of Nephrology. 2016;5(2):152–157. doi: 10.5527/wjn.v5.i2.152.
    1. Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, DC, USA: National Academies Press; 1997.
    1. Groenestege W. M., Hoenderop J. G., van den Heuvel L., Knoers N., Bindels R. J. The epithelial Mg2+ channel transient receptor potential melastatin 6 is regulated by dietary Mg2+ content and estrogens. Journal of the American Society of Nephrology. 2006;17(4):1035–1043. doi: 10.1681/ASN.2005070700.
    1. Brown E. M., MacLeod R. J. Extracellular calcium sensing and extracellular calcium signaling. Physiological Reviews. 2001;81(1):239–297. doi: 10.1152/physrev.2001.81.1.239.
    1. Mutnuri S., Fernandez I., Kochar T. Suppression of parathyroid hormone in a patient with severe magnesium depletion. Case Reports in Nephrology. 2016;2016:3. doi: 10.1155/2016/2608538.2608538
    1. Vetter T., Lohse M. J. Magnesium and the parathyroid. Current Opinion in Nephrology and Hypertension. 2002;11(4):403–410. doi: 10.1097/00041552-200207000-00006.
    1. Quitterer U., Hoffmann M., Freichel M., Lohse M. J. Paradoxical block of parathormone secretion is mediated by increased activity of Gα subunits. The Journal of Biological Chemistry. 2001;276(9):6763–6769. doi: 10.1074/jbc.M007727200.
    1. Sontia B., Touyz R. M. Magnesium transport in hypertension. Pathophysiology. 2007;14(3-4):205–211. doi: 10.1016/j.pathophys.2007.09.005.
    1. Monteilh-Zoller M. K., Hermosura M. C., Nadler M. J. S., Scharenberg A. M., Penner R., Fleig A. TRPM7 provides an ion channel mechanism for cellular entry of trace metal ions. The Journal of General Physiology. 2002;121(1):49–60. doi: 10.1085/jgp.20028740.
    1. Schlingmann K. P., Gudermann T. A critical role of TRPM channel-kinase for human magnesium transport. The Journal of Physiology. 2005;566(2):301–308. doi: 10.1113/jphysiol.2004.080200.
    1. Pilchova I., Klacanova K., Tatarkova Z., Kaplan P., Racay P. The involvement of Mg2+ in regulation of cellular and mitochondrial functions. Oxidative Medicine and Cellular Longevity. 2017;2017:8. doi: 10.1155/2017/6797460.6797460
    1. Gold M. E., Buga G. M., Wood K. S., Byrns R. E., Chaudhuri G., Ignarro L. J. Antagonistic modulatory roles of magnesium and calcium on release of endothelium-derived relaxing factor and smooth muscle tone. Circulation Research. 1990;66(2):355–366. doi: 10.1161/01.RES.66.2.355.
    1. Martin K. J., Gonzalez E. A., Slatopolsky E. Clinical consequences and management of hypomagnesemia. Journal of American Society of Nephrology. 2009;20(11):2291–2295. doi: 10.1681/ASN.2007111194.
    1. Viering D. H. H. M., de Baaij J. H. F., Walsh S. B., Kleta R., Bockenhauer D. Genetic causes of hypomagnesemia, a clinical overview. Pediatric Nephrology. 2017;32(7):1123–1135. doi: 10.1007/s00467-016-3416-3.
    1. Ryan M. F. The role of magnesium in clinical biochemistry: an overview. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine. 1991;28(1):19–26. doi: 10.1177/000456329102800103.
    1. Williamson M. A., Snyder L. M., Wallach J. B. Wallach's Interpretation of Diagnostic Tests. 9th. Philadelphia, PA, USA: Wolters Kluwer/Lippincott Williams & Wilkins; 2011. xvi, 1143.
    1. Millart H., Durlach V., Durlach J. Red blood cell magnesium concentrations: analytical problems and significance. Magnesium Research. 1995;8(1):65–76.
    1. Chernow B. Hypomagnesemia in intensive care correction of units. Chest. 1989;95(6):p. 1362. doi: 10.1378/chest.95.6.1362a.
    1. Schimatschek H. F., Rempis R. Prevalence of hypomagnesemia in an unselected German population of 16,000 individuals. Magnesium Research. 2001;14(4):283–290.
    1. Cheungpasitporn W., Thongprayoon C., Qian Q. Dysmagnesemia in hospitalized patients: prevalence and prognostic importance. Mayo Clinic Proceedings. 2015;90(8):1001–1010. doi: 10.1016/j.mayocp.2015.04.023.
    1. Pham P. C., Pham P. A., Pham S. V., Pham P. T., Pham P. M., Pham P. T. Hypomagnesemia: a clinical perspective. International Journal of Nephrology and Renovascular Disease. 2014;7:219–230. doi: 10.2147/ijnrd.s42054.
    1. Agus Z. S. Hypomagnesemia. Journal of the American Society of Nephrology. 1999;10(7):1616–1622.
    1. Lajer H., Daugaard G. Cisplatin and hypomagnesemia. Cancer Treatment Reviews. 1999;25(1):47–58. doi: 10.1053/ctrv.1999.0097.
    1. Bagnis C. I., Deray G. Amphotericin B nephrotoxicity. Saudi Journal of Kidney Diseases and Transplantation. 2002;13(4):481–491.
    1. Lee C. H., Kim G. H. Electrolyte and acid-base disturbances induced by clacineurin inhibitors. Electrolyte & Blood Pressure. 2007;5(2):126–130. doi: 10.5049/EBP.2007.5.2.126.
    1. Sivakumar J. Proton pump inhibitor-induced hypomagnesaemia and hypocalcaemia: case review. International Journal of Physiology, Pathophysiology and Pharmacology. 2016;8(4):169–174.
    1. Bergman C., Gray-Scott D., Chen J. J., Meacham S. What is next for the dietary reference intakes for bone metabolism related nutrients beyond calcium: phosphorus, magnesium, vitamin D, and fluoride? Critical Reviews in Food Science and Nutrition. 2009;49(2):136–144. doi: 10.1080/10408390701764468.
    1. Seo J. W., Park T. J. Magnesium metabolism. Electrolyte Blood Pressure. 2008;6(2):86–95. doi: 10.5049/EBP.2008.6.2.86.
    1. De Marchi S., Cecchin E., Basile A., Bertotti A., Nardini R., Bartoli E. Renal tubular dysfunction in chronic alcohol abuse--effects of abstinence. The New England Journal of Medicine. 1993;329(26):1927–1934. doi: 10.1056/NEJM199312233292605.
    1. Gradon J. D., Fricchione L., Sepkowitz D. Severe hypomagnesemia associated with pentamidine therapy. Reviews of Infectious Diseases. 1991;13(3):511–512. doi: 10.1093/clinids/13.3.511.
    1. Atsmon J., Dolev E. Drug-induced hypomagnesaemia: scope and management. Drug Safety. 2005;28(9):763–788. doi: 10.2165/00002018-200528090-00003.
    1. Fiaccadori E., Del Canale S., Coffrini E., et al. Muscle and serum magnesium in pulmonary intensive care unit patients. Critical Care Medicine. 1988;16(8):751–760. doi: 10.1097/00003246-198808000-00004.
    1. Guerin C., Cousin C., Mignot F., Manchon M., Fournier G. Serum and erythrocyte magnesium in critically ill patients. Intensive Care Medicine. 1996;22(8):724–727. doi: 10.1007/BF01709512.
    1. Escuela M. P., Guerra M., Anon J. M., et al. Total and ionized serum magnesium in critically ill patients. Intensive Care Medicine. 2005;31(1):151–156. doi: 10.1007/s00134-004-2508-x.
    1. Dabbagh O. C., Aldawood A. S., Arabi Y. M., Lone N. A., Brits R., Pillay M. Magnesium supplementation and the potential association with mortality rates among critically ill non-cardiac patients. Saudi Medical Journal. 2006;27(6):821–825.
    1. Zafar M. S. H., Wani J. I., Karim R., Mir M. M., Koul P. A. Significance of serum magnesium levels in critically ill-patients. International Journal of Applied Basic Medical Research. 2014;4(1):34–37. doi: 10.4103/2229-516X.125690.
    1. Chen M., Sun R., Hu B. The influence of serum magnesium level on the prognosis of critically ill patients. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015;27(3):213–217. doi: 10.3760/cma.j.issn.2095-4352.2015.03.011.
    1. Moskowitz A., Lee J., Donnino M. W., Mark R., Celi L. A., Danziger J. The association between admission magnesium concentrations and lactic acidosis in critical illness. Journal of Intensive Care Medicine. 2016;31(3):187–192. doi: 10.1177/0885066614530659.
    1. Soliman H. M., Mercan D., Lobo S. S. M., Melot C., Vincent J. L. Development of ionized hypomagnesemia is associated with higher mortality rates. Critical Care Medicine. 2003;31(4):1082–1087. doi: 10.1097/01.CCM.0000060867.17556.A0.
    1. Limaye C. S., Londhey V. A., Nadkart M. Y., Borges N. E. Hypomagnesemia in critically ill medical patients. The Journal of the Association of Physicians of India. 2011;59:19–22.
    1. Velissaris D., Karamouzos V., Pierrakos C., Aretha D., Karanikolas M. Hypomagnesemia in critically III sepsis patients. Journal of Clinical Medicine Research. 2015;7(12):911–918. doi: 10.14740/jocmr2351w.
    1. Upala S., Jaruvongvanich V., Wijarnpreecha K., Sanguankeo A. Hypomagnesemia and mortality in patients admitted to intensive care unit: a systematic review and meta-analysis. QJM: An International Journal of Medicine. 2016;109(7):453–459. doi: 10.1093/qjmed/hcw048.
    1. Arnold A., Tovey J., Mangat P., Penny W., Jacobs S. Magnesium deficiency in critically ill patients. Anaesthesia. 1995;50(3):203–205. doi: 10.1111/j.1365-2044.1995.tb04556.x.
    1. Charles B. S., Menon I., Girish T. S., Cherian A. M. Hypomagnesemia in the ICU - does correction matter? The Journal of the Association of Physicians of India. 2016;64(11):15–19.
    1. Moran J. L., Gallagher J., Peake S. L., Cunningham D. N., Salagaras M. C. N., Leppard P. Parenteral magnesium sulfate versus amiodarone in the therapy of atrial tachyarrhythmias: a prospective, randomized study. Critical Care Medicine. 1995;23(11):1816–1824. doi: 10.1097/00003246-199511000-00005.
    1. Kasaoka S., Tsuruta R., Nakashima K., et al. Effect of intravenous magnesium sulfate on cardiac arrhythmias in critically III patients with low serum ionized magnesium. Japanese Circulation Journal. 1996;60(11):871–875. doi: 10.1253/jcj.60.871.
    1. Sleeswijk M. E., Tulleken J. E., Van Noord T., Meertens J. H. J. M., Ligtenberg J. J. M., Zijlstra J. G. Efficacy of magnesium-amiodarone step-up scheme in critically ill patients with new-onset atrial fibrillation: a prospective observational study. Journal of Intensive Care Medicine. 2008;23(1):61–66. doi: 10.1177/0885066607310181.
    1. Panahi Y., Mojtahedzadeh M., Najafi A., et al. The role of magnesium sulfate in the intensive care unit. EXCLI Journal. 2017;16:464–482. doi: 10.17179/excli2017-182.
    1. Karahan M. A., Kucuk A., Buyukfirat E., Yalcin F. Acute respiratory and renal failure due to hypermagnesemia, induced by counter laxatives in an elderly man. Journal of Clinical and Diagnostic Research. 2015;9(12, article UL01) doi: 10.7860/JCDR/2015/16630.6939.
    1. Sugiyama M., Kusumoto E., Ota M., et al. Induction of potentially lethal hypermagnesemia, ischemic colitis, and toxic megacolon by a preoperative mechanical bowel preparation: report of a case. Surgical Case Reports. 2016;2(1):p. 18. doi: 10.1186/s40792-016-0145-6.
    1. Cruz K. J. C., de Oliveira A. R. S., Pinto D. P., et al. Influence of magnesium on insulin resistance in obese women. Biological Trace Element Research. 2014;160(3):305–310. doi: 10.1007/s12011-014-0044-2.
    1. Guerrero-Romero F., Rodriguez-Moran M. Magnesium improves the beta-cell function to compensate variation of insulin sensitivity: double-blind, randomized clinical trial. European Journal of Clinical Investigation. 2011;41(4):405–410. doi: 10.1111/j.1365-2362.2010.02422.x.
    1. Nielsen F. H., Milne D. B., Gallagher S., Johnson L., Hoverson B. Moderate magnesium deprivation results in calcium retention and altered potassium and phosphorus excretion by postmenopausal women. Magnesium Research. 2007;20(1):19–31.
    1. Nielsen F. H. Magnesium deficiency and increased inflammation: current perspectives. Journal of Inflammation Research. 2018;11:25–34. doi: 10.2147/JIR.S136742.
    1. Paolisso G., Sgambato S., Passariello N., et al. Insulin induces opposite changes in plasma and erythrocyte magnesium concentrations in normal man. Diabetologia. 1986;29(9):644–647. doi: 10.1007/BF00869264.
    1. Xu L. H. R., Maalouf N. M. Effect of acute hyperinsulinemia on magnesium homeostasis in humans. Diabetes/Metabolism Research and Reviews. 2017;33(2) doi: 10.1002/dmrr.2844.
    1. McNair P., Christensen M. S., Christiansen C., Madsbad S., Transbol I. Renal hypomagnesaemia in human diabetes mellitus: its relation to glucose homeostasis. European Journal of Clinical Investigation. 1982;12(1):81–85. doi: 10.1111/j.1365-2362.1982.tb00942.x.
    1. Matsunobu S., Terashima Y., Senshu T., Sano H., Itoh H. Insulin secretion and glucose uptake in hypomagnesemic sheep fed a low magnesium, high potassium diet. The Journal of Nutritional Biochemistry. 1990;1(3):167–171. doi: 10.1016/0955-2863(90)90018-G.
    1. Suárez A., Pulido N., Casla A., Casanova B., Arrieta F. J., Rovira A. Impaired tyrosine-kinase activity of muscle insulin receptors from hypomagnesaemic rats. Diabetologia. 1995;38(11):1262–1270. doi: 10.1007/BF00401757.
    1. Kao W. H. L., Folsom A. R., Nieto F. J., Mo J. P., Watson R. L., Brancati F. L. Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the atherosclerosis risk in communities study. Archives of Internal Medicine. 1999;159(18):2151–2159. doi: 10.1001/archinte.159.18.2151.
    1. Resnick L. M., Altura B. T., Gupta R. K., Laragh J. H., Alderman M. H., Altura B. M. Intracellular and extracellular magnesium depletion in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1993;36(8):767–770. doi: 10.1007/BF00401149.
    1. Barbagallo M., Dominguez L. J., Galioto A., et al. Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Molecular Aspects of Medicine. 2003;24(1–3):39–52. doi: 10.1016/S0098-2997(02)00090-0.
    1. Larsson S. C., Wolk A. Magnesium intake and risk of type 2 diabetes: a meta-analysis. Journal of Internal Medicine. 2007;262(2):208–214. doi: 10.1111/j.1365-2796.2007.01840.x.
    1. Hruby A., Meigs J. B., O'Donnell C. J., Jacques P. F., McKeown N. M. Higher magnesium intake reduces risk of impaired glucose and insulin metabolism and progression from prediabetes to diabetes in middle-aged Americans. Diabetes Care. 2014;37(2):419–427. doi: 10.2337/dc13-1397.
    1. Guerrero-Romero F., Simental-Mendia L. E., Hernandez-Ronquillo G., Rodriguez-Moran M. Oral magnesium supplementation improves glycaemic status in subjects with prediabetes and hypomagnesaemia: a double-blind placebo-controlled randomized trial. Diabetes & Metabolism. 2015;41(3):202–207. doi: 10.1016/j.diabet.2015.03.010.
    1. Rodriguez-Moran M., Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care. 2003;26(4):1147–1152. doi: 10.2337/diacare.26.4.1147.
    1. Bherwani S., Jibhkate S. B., Saumya A. S., Patel S. K., Singh R., Ghotekar L. H. Hypomagnesaemia: a modifiable risk factor of diabetic nephropathy. Hormone Molecular Biology and Clinical Investigation. 2017;29(3):79–84. doi: 10.1515/hmbci-2016-0024.
    1. Ramadass S., Basu S., Srinivasan A. R. Serum magnesium levels as an indicator of status of diabetes mellitus type 2. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2015;9(1):42–45. doi: 10.1016/j.dsx.2014.04.024.
    1. Guerrero-Romero F., Rodriguez-Moran M. Hypomagnesemia is linked to low serum HDL-cholesterol irrespective of serum glucose values. Journal of Diabetes and its Complications. 2000;14(5):272–276. doi: 10.1016/S1056-8727(00)00127-6.
    1. Corica F., Corsonello A., Ientile R., et al. Serum ionized magnesium levels in relation to metabolic syndrome in type 2 diabetic patients. Journal of the American College of Nutrition. 2006;25(3):210–215. doi: 10.1080/07315724.2006.10719534.
    1. Asemi Z., Karamali M., Jamilian M., et al. Magnesium supplementation affects metabolic status and pregnancy outcomes in gestational diabetes: a randomized, double-blind, placebo-controlled trial. The American Journal of Clinical Nutrition. 2015;102(1):222–229. doi: 10.3945/ajcn.114.098616.
    1. Jamilian M., Samimi M., Faraneh A. E., et al. Magnesium supplementation affects gene expression related to insulin and lipid in patients with gestational diabetes. Magnesium Research. 2017;30(3):71–79. doi: 10.1684/mrh.2017.0425.
    1. Lin C. C., Huang Y. L. Chromium, zinc and magnesium status in type 1 diabetes. Current Opinion in Clinical Nutrition and Metabolic Care. 2015;18(6):588–592. doi: 10.1097/MCO.0000000000000225.
    1. Galli-Tsinopoulou A., Maggana I., Kyrgios I., et al. Association between magnesium concentration and HbA1c in children and adolescents with type 1 diabetes mellitus. Journal of Diabetes. 2014;6(4):369–377. doi: 10.1111/1753-0407.12118.
    1. Djurhuus M. S., Klitgaard N. A. H., Pedersen K. K., et al. Magnesium reduces insulin-stimulated glucose uptake and serum lipid concentrations in type 1 diabetes. Metabolism. 2001;50(12):1409–1417. doi: 10.1053/meta.2001.28072.
    1. Atabek M. E., Kurtoglu S., Pirgon O., Baykara M. Serum magnesium concentrations in type 1 diabetic patients: relation to early atherosclerosis. Diabetes Research and Clinical Practice. 2006;72(1):42–47. doi: 10.1016/j.diabres.2005.09.002.
    1. Shahbah D., Hassan T., Morsy S., et al. Oral magnesium supplementation improves glycemic control and lipid profile in children with type 1 diabetes and hypomagnesaemia. Medicine. 2017;96(11, article e6352) doi: 10.1097/MD.0000000000006352.
    1. De Leeuw I., Engelen W., De Block C., Van Gaal L. Long term magnesium supplementation influences favourably the natural evolution of neuropathy in Mg-depleted type 1 diabetic patients (T1dm) Magnesium Research. 2004;17(2):109–114.
    1. Freedman A. M., Mak I. T., Stafford R. E., et al. Erythrocytes from magnesium-deficient hamsters display an enhanced susceptibility to oxidative stress. American Journal of Physiology-Cell Physiology. 1992;262(6):C1371–C1375. doi: 10.1152/ajpcell.1992.262.6.C1371.
    1. Guerrero-Romero F., Bermudez-Pena C., Rodriguez-Moran M. Severe hypomagnesemia and low-grade inflammation in metabolic syndrome. Magnesium Research. 2011;24(2):45–53. doi: 10.1684/mrh.2011.0281.
    1. Guerrero-Romero F., Rodriguez-Moran M. Relationship between serum magnesium levels and C-reactive protein concentration, in non-diabetic, non-hypertensive obese subjects. International Journal of Obesity and Related Metabolic Disorders. 2002;26(4):469–474. doi: 10.1038/sj.ijo.0801954.
    1. Song Y., Li T. Y., van Dam R. M., Manson J. A. E., Hu F. B. Magnesium intake and plasma concentrations of markers of systemic inflammation and endothelial dysfunction in women. The American Journal of Clinical Nutrition. 2007;85(4):1068–1074. doi: 10.1093/ajcn/85.4.1068.
    1. Dibaba D. T., Xun P., He K. Dietary magnesium intake is inversely associated with serum C-reactive protein levels: meta-analysis and systematic review. European Journal of Clinical Nutrition. 2014;68(4):510–516. doi: 10.1038/ejcn.2014.7.
    1. Morais J. B. S., Severo J. S., de Alencar G. R. R., et al. Effect of magnesium supplementation on insulin resistance in humans: a systematic review. Nutrition. 2017;38:54–60. doi: 10.1016/j.nut.2017.01.009.
    1. Kisters K., Spieker C., Tepel M., Zidek W. New data about the effects of oral physiological magnesium supplementation on several cardiovascular risk factors (lipids and blood pressure) Magnesium Research. 1993;6(4):355–360.
    1. Yokota K., Kato M., Lister F., et al. Clinical efficacy of magnesium supplementation in patients with type 2 diabetes. Journal of the American College of Nutrition. 2004;23(5):506S–509S. doi: 10.1080/07315724.2004.10719390.
    1. Castiglioni S., Cazzaniga A., Albisetti W., Maier J. A. Magnesium and osteoporosis: current state of knowledge and future research directions. Nutrients. 2013;5(8):3022–3033. doi: 10.3390/nu5083022.
    1. Alfrey A. C., Miller N. L. Bone magnesium pools in uremia. The Journal of Clinical Investigation. 1973;52(12):3019–3027. doi: 10.1172/JCI107500.
    1. Saito N., Tabata N., Saito S., et al. Bone mineral density, serum albumin and serum magnesium. Journal of the American College of Nutrition. 2004;23(6):701S–703S. doi: 10.1080/07315724.2004.10719412.
    1. Mahdavi-Roshan M., Ebrahimi M., Ebrahimi A. Copper, magnesium, zinc and calcium status in osteopenic and osteoporotic post-menopausal women. Clinical Cases in Mineral and Bone Metabolism. 2015;12(1):18–21. doi: 10.11138/ccmbm/2015.12.1.018.
    1. Czeczuk A., Huk-Wieliczuk E., Dmitruk A., Poplawska H. An analysis of selected risk factors of osteoporosis - dietary patterns and physical activity - in pubescent girls from the Lubelskie province. Przegla̧d Epidemiologiczny. 2017;71(1):99–110.
    1. Tucker K. L., Hannan M. T., Chen H., Cupples L. A., Wilson P. W. F., Kiel D. P. Potassium, magnesium, and fruit and vegetable intakes are associated with greater bone mineral density in elderly men and women. The American Journal of Clinical Nutrition. 1999;69(4):727–736. doi: 10.1093/ajcn/69.4.727.
    1. Tranquilli A. L., Lucino E., Garzetti G. G., Romanini C. Calcium, phosphorus and magnesium intakes correlate with bone mineral content in postmenopausal women. Gynecological Endocrinology. 1994;8(1):55–58. doi: 10.3109/09513599409028459.
    1. Orchard T. S., Larson J. C., Alghothani N., et al. Magnesium intake, bone mineral density, and fractures: results from the Women’s Health Initiative Observational Study. The American Journal of Clinical Nutrition. 2014;99(4):926–933. doi: 10.3945/ajcn.113.067488.
    1. Wang M. C., Moore E. C., Crawford P. B., et al. Influence of pre-adolescent diet on quantitative ultrasound measurements of the calcaneus in young adult women. Osteoporosis International. 1999;9(6):532–535. doi: 10.1007/s001980050181.
    1. Carpenter T. O., DeLucia M. C., Zhang J. H., et al. A randomized controlled study of effects of dietary magnesium oxide supplementation on bone mineral content in healthy girls. The Journal of Clinical Endocrinology & Metabolism. 2006;91(12):4866–4872. doi: 10.1210/jc.2006-1391.
    1. Matias C. N., Santos D. A., Monteiro C. P., et al. Magnesium intake mediates the association between bone mineral density and lean soft tissue in elite swimmers. Magnesium Research. 2012;25(3):120–125. doi: 10.1684/mrh.2012.0317.
    1. Veronese N., Stubbs B., Solmi M., et al. Dietary magnesium intake and fracture risk: data from a large prospective study. British Journal of Nutrition. 2017;117(11):1570–1576. doi: 10.1017/S0007114517001350.
    1. Cohen L., Kitzes R. Infrared spectroscopy and magnesium content of bone mineral in osteoporotic women. Israel Journal of Medical Sciences. 1981;17(12):1123–1125.
    1. Warburton D. E., Nicol C. W., Gatto S. N., Bredin S. S. Cardiovascular disease and osteoporosis: balancing risk management. Vascular Health and Risk Management. 2007;3(5):673–689.
    1. Mazur A., Maier J. A. M., Rock E., Gueux E., Nowacki W., Rayssiguier Y. Magnesium and the inflammatory response: potential physiopathological implications. Archives of Biochemistry and Biophysics. 2007;458(1):48–56. doi: 10.1016/j.abb.2006.03.031.
    1. Reddy V., Sivakumar B. Magnesium-dependent vitamin-D-resistant rickets. Lancet. 1974;1(7864):963–965.
    1. Shechter M., Merz C. N. B., Paul-Labrador M., et al. Oral magnesium supplementation inhibits platelet-dependent thrombosis in patients with coronary artery disease. The American Journal of Cardiology. 1999;84(2):152–156. doi: 10.1016/S0002-9149(99)00225-8.
    1. Shechter M., Bairey Merz C. N., Stuehlinger H. G., Slany J., Pachinger O., Rabinowitz B. Effects of oral magnesium therapy on exercise tolerance, exercise-induced chest pain, and quality of life in patients with coronary artery disease. The American Journal of Cardiology. 2003;91(5):517–521. doi: 10.1016/S0002-9149(02)03297-6.
    1. Pokan R., Hofmann P., von Duvillard S. P., et al. Oral magnesium therapy, exercise heart rate, exercise tolerance, and myocardial function in coronary artery disease patients. British Journal of Sports Medicine. 2006;40(9):773–778. doi: 10.1136/bjsm.2006.027250.
    1. Qu X., Jin F., Hao Y., et al. Magnesium and the risk of cardiovascular events: a meta-analysis of prospective cohort studies. PLoS One. 2013;8(3, article e57720) doi: 10.1371/journal.pone.0057720.
    1. Del Gobbo L. C., Song Y., Poirier P., Dewailly E., Elin R. J., Egeland G. M. Low serum magnesium concentrations are associated with a high prevalence of premature ventricular complexes in obese adults with type 2 diabetes. Cardiovascular Diabetology. 2012;11(1):p. 23. doi: 10.1186/1475-2840-11-23.
    1. Efstratiadis G., Sarigianni M., Gougourelas I. Hypomagnesemia and cardiovascular system. Hippokratia. 2006;10(4):147–152.
    1. Markovits N., Kurnik D., Halkin H., et al. Database evaluation of the association between serum magnesium levels and the risk of atrial fibrillation in the community. International Journal of Cardiology. 2016;205:142–146. doi: 10.1016/j.ijcard.2015.12.014.
    1. Klinger R. Y., Thunberg C. A., White W. D., et al. Intraoperative magnesium administration does not reduce postoperative atrial fibrillation after cardiac surgery. Anesthesia & Analgesia. 2015;121(4):861–867. doi: 10.1213/ANE.0000000000000873.
    1. Janeira L. F. Torsades de pointes and long QT syndromes. American Family Physician. 1995;52(5):1447–1453.
    1. Isayama S., Ushijima K., Sakanashi Y., Yano T., Terasaki H. Sudden ventricular tachyarrhythmia immediately following hepatectomy in a patient with hypomagnesemia. Masui. 1998;47(4):470–474.
    1. Onagawa T., Ohkuchi A., Ohki R., et al. Woman with postpartum ventricular tachycardia and hypomagnesemia. The Journal of Obstetrics and Gynaecology Research. 2003;29(2):92–95. doi: 10.1046/j.1341-8076.2003.00085.x.
    1. Kaye A. D., Volpi-Abadie J., Bensler J. M., Kaye A. M., Diaz J. H. QT interval abnormalities: risk factors and perioperative management in long QT syndromes and Torsades de Pointes. Journal of Anesthesia. 2013;27(4):575–587. doi: 10.1007/s00540-013-1564-1.
    1. De Falco C. N. M. L., Grupi C., Sosa E., et al. Successful improvement of frequency and symptoms of premature complexes after oral magnesium administration. Arquivos Brasileiros de Cardiologia. 2012;98(6):480–487. doi: 10.1590/S0066-782X2012005000043.
    1. Young I. S., Goh E. M., McKillop U. H., Stanford C. F., Nicholls D. P., Trimble E. R. Magnesium status and digoxin toxicity. British Journal of Clinical Pharmacology. 1991;32(6):717–721.
    1. Cohen L., Kitzes R. Magnesium sulfate and digitalis-toxic arrhythmias. Journal of the American Medical Association. 1983;249(20):2808–2810. doi: 10.1001/jama.1983.03330440046030.
    1. Raja Rao M. P., Panduranga P., Sulaiman K., Al-Jufaili M. Digoxin toxicity with normal digoxin and serum potassium levels: beware of magnesium, the hidden malefactor. The Journal of Emergency Medicine. 2013;45(2):e31–e34. doi: 10.1016/j.jemermed.2012.11.111.
    1. Lewis R. V., Tregaskis B., McLay J., Service E., McDevitt D. G. Oral magnesium reduces ventricular ectopy in digitalised patients with chronic atrial fibrillation. European Journal of Clinical Pharmacology. 1990;38(2):107–110.
    1. Ford E. S. Serum magnesium and ischaemic heart disease: findings from a national sample of US adults. International Journal of Epidemiology. 1999;28(4):645–651. doi: 10.1093/ije/28.4.645.
    1. He K., Liu K., Daviglus M. L., et al. Magnesium intake and incidence of metabolic syndrome among young adults. Circulation. 2006;113(13):1675–1682. doi: 10.1161/CIRCULATIONAHA.105.588327.
    1. Kieboom B. C. T., Niemeijer M. N., Leening M. J. G., et al. Serum magnesium and the risk of death from coronary heart disease and sudden cardiac death. Journal of the American Heart Association. 2016;5(1, article e002707) doi: 10.1161/JAHA.115.002707.
    1. Jiang L., He P., Chen J., et al. Magnesium levels in drinking water and coronary heart disease mortality risk: a meta-analysis. Nutrients. 2016;8(1) doi: 10.3390/nu8010005.
    1. Liao F., Folsom A. R., Brancati F. L. Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study. American Heart Journal. 1998;136(3):480–490. doi: 10.1016/S0002-8703(98)70224-8.
    1. Shechter M., Sharir M., Labrador M. J. P., Forrester J., Silver B., Bairey Merz C. N. Oral magnesium therapy improves endothelial function in patients with coronary artery disease. Circulation. 2000;102(19):2353–2358. doi: 10.1161/01.CIR.102.19.2353.
    1. Shafiq A., Goyal A., Jones P. G., et al. Serum magnesium levels and in-hospital mortality in acute myocardial infarction. Journal of the American College of Cardiology. 2017;69(22):2771–2772. doi: 10.1016/j.jacc.2017.03.579.
    1. Li J., Zhang Q., Zhang M., Egger M. Intravenous magnesium for acute myocardial infarction. The Cochrane Database of Systematic Reviews. 2007;(2, article CD002755) doi: 10.1002/14651858.CD002755.pub2.
    1. An G., Du Z., Meng X., et al. Association between low serum magnesium level and major adverse cardiac events in patients treated with drug-eluting stents for acute myocardial infarction. PLoS One. 2014;9(6, article e98971) doi: 10.1371/journal.pone.0098971.
    1. Monarca S., Zerbini I., Simonati C., Gelatti U. Drinking water hardness and chronic degenerative diseases. II. Cardiovascular diseases. Annali di Igiene. 2003;15(1):41–56.
    1. Yang C. Y., Chiu H. F., Chiu J. F., Wang T. N., Cheng M. F. Magnesium and calcium in drinking water and cerebrovascular mortality in Taiwan. Magnesium Research. 1997;10(1):51–57.
    1. Rubenowitz E., Molin I., Axelsson G., Rylander R. Magnesium in drinking water in relation to morbidity and mortality from acute myocardial infarction. Epidemiology. 2000;11(4):416–421. doi: 10.1097/00001648-200007000-00009.
    1. Rosanoff A. The high heart health value of drinking-water magnesium. Medical Hypotheses. 2013;81(6):1063–1065. doi: 10.1016/j.mehy.2013.10.003.
    1. Paravicini T. M., Yogi A., Mazur A., Touyz R. M. Dysregulation of vascular TRPM7 and annexin-1 is associated with endothelial dysfunction in inherited hypomagnesemia. Hypertension. 2009;53(2):423–429. doi: 10.1161/HYPERTENSIONAHA.108.124651.
    1. Abad C., Vargas F. R., Zoltan T., et al. Magnesium sulfate affords protection against oxidative damage during severe preeclampsia. Placenta. 2015;36(2):179–185. doi: 10.1016/j.placenta.2014.11.008.
    1. McDonald S. D., Lutsiv O., Dzaja N., Duley L. A systematic review of maternal and infant outcomes following magnesium sulfate for pre-eclampsia/eclampsia in real-world use. International Journal of Gynecology & Obstetrics. 2012;118(2):90–96. doi: 10.1016/j.ijgo.2012.01.028.
    1. Ceremuzynski L., Gebalska J., Wolk R., Makowska E. Hypomagnesemia in heart failure with ventricular arrhythmias. Beneficial effects of magnesium supplementation. Journal of Internal Medicine. 2000;247(1):78–86. doi: 10.1046/j.1365-2796.2000.00585.x.
    1. Wester P. O., Dyckner T. Intracellular electrolytes in cardiac failure. Acta Medica Scandinavica. 1986;219(S707):33–36. doi: 10.1111/j.0954-6820.1986.tb18112.x.
    1. Angkananard T., Anothaisintawee T., Eursiriwan S., et al. The association of serum magnesium and mortality outcomes in heart failure patients: a systematic review and meta-analysis. Medicine. 2016;95(50, article e5406) doi: 10.1097/MD.0000000000005406.
    1. Mayer M. L., Westbrook G. L., Guthrie P. B. Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones. Nature. 1984;309(5965):261–263. doi: 10.1038/309261a0.
    1. Baratloo A., Mirbaha S., Delavar Kasmaei H., Payandemehr P., Elmaraezy A., Negida A. Intravenous caffeine citrate vs. magnesium sulfate for reducing pain in patients with acute migraine headache; a prospective quasi-experimental study. The Korean Journal of Pain. 2017;30(3):176–182. doi: 10.3344/kjp.2017.30.3.176.
    1. Schoenen J., Sianard-Gainko J., Lenaerts M. Blood magnesium levels in migraine. Cephalalgia. 1991;11(2):97–99. doi: 10.1046/j.1468-2982.1991.1102097.x.
    1. Samaie A., Asghari N., Ghorbani R., Arda J. Blood magnesium levels in migraineurs within and between the headache attacks: a case control study. The Pan African Medical Journal. 2012;11:p. 46.
    1. Ramadan N. M., Halvorson H., Vande-Linde A., Levine S. R., Helpern J. A., Welch K. M. A. Low brain magnesium in migraine. Headache. 1989;29(9):590–593. doi: 10.1111/j.1526-4610.1989.hed2909590.x.
    1. Leo A. A. P. Further observations on the spreading depression of activity in the cerebral cortex. Journal of Neurophysiology. 1947;10(6):409–414. doi: 10.1152/jn.1947.10.6.409.
    1. Cete Y., Dora B., Ertan C., Ozdemir C., Oktay C. A randomized prospective placebo-controlled study of intravenous magnesium sulphate vs. metoclopramide in the management of acute migraine attacks in the emergency department. Cephalalgia. 2005;25(3):199–204. doi: 10.1111/j.1468-2982.2004.00840.x.
    1. Shahrami A., Assarzadegan F., Hatamabadi H. R., Asgarzadeh M., Sarehbandi B., Asgarzadeh S. Comparison of therapeutic effects of magnesium sulfate vs. dexamethasone/metoclopramide on alleviating acute migraine headache. The Journal of Emergency Medicine. 2015;48(1):69–76. doi: 10.1016/j.jemermed.2014.06.055.
    1. Mauskop A., Altura B. T., Cracco R. Q., Altura B. M. Intravenous magnesium sulfate rapidly alleviates headaches of various types. Headache. 1996;36(3):154–160. doi: 10.1046/j.1526-4610.1996.3603154.x.
    1. Dorhout Mees S. M., Bertens D., van der Worp H. B., Rinkel G. J. E., van den Bergh W. M. Magnesium and headache after aneurysmal subarachnoid haemorrhage. Journal of Neurology, Neurosurgery, and Psychiatry. 2010;81(5):490–493. doi: 10.1136/jnnp.2009.181404.
    1. Facchinetti F., Sances G., Borella P., Genazzani A. R., Nappi G. Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache. 1991;31(5):298–301. doi: 10.1111/j.1526-4610.1991.hed3105298.x.
    1. Opavsky J. Magnesium and its combination with cinnarizine in the long-term treatment of headache. Acta Universitatis Palackianae Olomucensis Facultatis Medicae. 1991;131:157–164.
    1. Choi H., Parmar N. The use of intravenous magnesium sulphate for acute migraine: meta-analysis of randomized controlled trials. European Journal of Emergency Medicine. 2014;21(1):2–9. doi: 10.1097/MEJ.0b013e3283646e1b.
    1. Castilla-Guerra L., del Carmen Fernández-Moreno M., López-Chozas J. M., Fernández-Bolaños R. Electrolytes disturbances and seizures. Epilepsia. 2006;47(12):1990–1998. doi: 10.1111/j.1528-1167.2006.00861.x.
    1. Chen B. B., Prasad C., Kobrzynski M., Campbell C., Filler G. Seizures related to hypomagnesemia: a case series and review of the literature. Child Neurology Open. 2016;3, article 2329048X16674834 doi: 10.1177/2329048X16674834.
    1. Sibai B. M. Magnesium sulfate is the ideal anticonvulsant in preeclampsia-eclampsia. American Journal of Obstetrics and Gynecology. 1990;162(5):1141–1145. doi: 10.1016/0002-9378(90)90002-O.
    1. Barton J. R., Sibai B. M., Ahokas R. A., Whybrew W. D., Mercer B. M. Magnesium sulfate therapy in preeclampsia is associated with increased urinary cyclic guanosine monophosphate excretion. American Journal of Obstetrics and Gynecology. 1992;167(4):931–934. doi: 10.1016/S0002-9378(12)80014-7.
    1. Chinayon P. Clinical management and outcome of eclampsia at Rajavithi Hospital. Journal of the Medical Association of Thailand. 1998;81(8):579–585.
    1. Abdelmalik P. A., Politzer N., Carlen P. L. Magnesium as an effective adjunct therapy for drug resistant seizures. The Canadian Journal of Neurological Sciences. 2012;39(3):323–327. doi: 10.1017/S0317167100013457.
    1. Ohira T., Peacock J. M., Iso H., Chambless L. E., Rosamond W. D., Folsom A. R. Serum and dietary magnesium and risk of ischemic stroke: the Atherosclerosis Risk in Communities Study. American Journal of Epidemiology. 2009;169(12):1437–1444. doi: 10.1093/aje/kwp071.
    1. Adebamowo S. N., Spiegelman D., Willett W. C., Rexrode K. M. Association between intakes of magnesium, potassium, and calcium and risk of stroke: 2 cohorts of US women and updated meta-analyses. The American Journal of Clinical Nutrition. 2015;101(6):1269–1277. doi: 10.3945/ajcn.114.100354.
    1. Bain L. K. M., Myint P. K., Jennings A., et al. The relationship between dietary magnesium intake, stroke and its major risk factors, blood pressure and cholesterol, in the EPIC-Norfolk cohort. International Journal of Cardiology. 2015;196:108–114. doi: 10.1016/j.ijcard.2015.05.166.
    1. You S., Zhong C., Du H., et al. Admission low magnesium level is associated with in-hospital mortality in acute ischemic stroke patients. Cerebrovascular Diseases. 2017;44(1-2):35–42. doi: 10.1159/000471858.
    1. Cojocaru I. M., Cojocaru M., Burcin C., Atanasiu N. A. Serum magnesium in patients with acute ischemic stroke. Romanian Journal of Internal Medicine. 2007;45(3):269–273.
    1. Saver J. L., Starkman S., Eckstein M., et al. Prehospital use of magnesium sulfate as neuroprotection in acute stroke. The New England Journal of Medicine. 2015;372(6):528–536. doi: 10.1056/NEJMoa1408827.
    1. Britton J., Pavord I., Richards K., et al. Dietary magnesium, lung function, wheezing, and airway hyperreactivity in a random adult population sample. The Lancet. 1994;344(8919):357–362. doi: 10.1016/S0140-6736(94)91399-4.
    1. do Amaral A. F., Rodrigues-Junior A. L., Terra Filho J., Vannucchi H., Martinez J. A. Effects of acute magnesium loading on pulmonary function of stable COPD patients. Medical Science Monitor. 2008;14(10):CR524–CR529.
    1. Skobeloff E. M., Spivey W. H., McNamara R. M., Greenspon L. Intravenous magnesium sulfate for the treatment of acute asthma in the emergency department. Journal of the American Medical Association. 1989;262(9):1210–1213. doi: 10.1001/jama.1989.03430090072036.
    1. Kew K. M., Kirtchuk L., Michell C. I. Intravenous magnesium sulfate for treating adults with acute asthma in the emergency department. Cochrane Database of Systematic Reviews. 2014;5, article CD010909 doi: 10.1002/14651858.cd010909.pub2.
    1. Hughes R., Goldkorn A., Masoli M., Weatherall M., Burgess C., Beasley R. Use of isotonic nebulised magnesium sulphate as an adjuvant to salbutamol in treatment of severe asthma in adults: randomised placebo-controlled trial. The Lancet. 2003;361(9375):2114–2117. doi: 10.1016/S0140-6736(03)13721-X.
    1. Cairns C. B., Kraft M. Magnesium attenuates the neutrophil respiratory burst in adult asthmatic patients. Academic Emergency Medicine. 1996;3(12):1093–1097. doi: 10.1111/j.1553-2712.1996.tb03366.x.
    1. Aziz H. S., Blamoun A. I., Shubair M. K., Ismail M. M., DeBari V. A., Khan M. A. Serum magnesium levels and acute exacerbation of chronic obstructive pulmonary disease: a retrospective study. Annals of Clinical and Laboratory Science. 2005;35(4):423–427.
    1. Bhatt S. P., Khandelwal P., Nanda S., Stoltzfus J. C., Fioravanti G. T. Serum magnesium is an independent predictor of frequent readmissions due to acute exacerbation of chronic obstructive pulmonary disease. Respiratory Medicine. 2008;102(7):999–1003. doi: 10.1016/j.rmed.2008.02.010.
    1. Shivanthan M. C., Rajapakse S. Magnesium for acute exacerbation of chronic obstructive pulmonary disease: a systematic review of randomised trials. Annals of Thoracic Medicine. 2014;9(2):77–80. doi: 10.4103/1817-1737.128844.
    1. Gumus A., Haziroglu M., Gunes Y. Association of serum magnesium levels with frequency of acute exacerbations in chronic obstructive pulmonary disease: a prospective study. Pulmonary Medicine. 2014;2014:5. doi: 10.1155/2014/329476.329476
    1. Mountokalakis T. D. Magnesium metabolism in chronic renal failure. Magnesium Research. 1990;3(2):121–127.
    1. Cunningham J., Rodriguez M., Messa P. Magnesium in chronic kidney disease stages 3 and 4 and in dialysis patients. Clinical Kidney Journal. 2012;5(Supplement 1):i39–i51. doi: 10.1093/ndtplus/sfr166.
    1. Floridis J., Abeyaratne A., Majoni S. W. Prevalence and clinical impact of magnesium disorders in end-stage renal disease: a protocol for a systematic review. Systematic Reviews. 2015;4(1):p. 76. doi: 10.1186/s13643-015-0063-x.
    1. Huang J. H., Cheng F. C., Wu H. C. Low magnesium exacerbates osteoporosis in chronic kidney disease patients with diabetes. International Journal of Endocrinology. 2015;2015:10. doi: 10.1155/2015/380247.380247
    1. Cai K., Luo Q., Dai Z., et al. Hypomagnesemia is associated with increased mortality among peritoneal dialysis patients. PLoS One. 2016;11(3, article e0152488) doi: 10.1371/journal.pone.0152488.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다